Genomic approaches in the management and treatment of breast cancer

por Chang, J C, Hilsenbeck, S G, Fuqua, S A W
Publicado 2005

The promise of microarrays in the management and treatment of breast cancer

por Chang, Jenny C, Hilsenbeck, Susan G, Fuqua, Suzanne AW
Publicado 2005

The role of single nucleotide polymorphisms in breast cancer metastasis

por Rae, James M, Skaar, Todd C, Hilsenbeck, Susan G, Oesterreich, Steffi
Publicado 2008

Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors

por Daves, Marla H, Hilsenbeck, Susan G, Lau, Ching C, Man, Tsz-Kwong
Publicado 2011

Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer

por Lee, Sangjun, Mohsin, Syed K, Mao, Sufeng, Hilsenbeck, Susan G, Medina, Dan, Allred, D Craig
Publicado 2006

Krt6a-Positive Mammary Epithelial Progenitors Are Not at Increased Vulnerability to Tumorigenesis Initiated by ErbB2

por Holloway, Kimberly R., Sinha, Vidya C., Toneff, Michael J., Bu, Wen, Hilsenbeck, Susan G., Li, Yi
Publicado 2015

Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome

por Xu, Jia, Shetty, Priya B, Feng, Weiwei, Chenault, Carol, Bast, Robert C, Hilsenbeck, Susan G, Yu, Yinhua
Publicado 2012

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

por Shepherd, Jonathan H., Uray, Ivan P., Mazumdar, Abhijit, Tsimelzon, Anna, Savage, Michelle, Hilsenbeck, Susan G., Brown, Powel H.
Publicado 2016

Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3

por Alten, Jeffrey A., Moran, Ana, Tsimelzon, Anna I., Mastrangelo, Mary-Ann A., Hilsenbeck, Susan G., Poli, Valeria, Tweardy, David J.
Publicado 2008

Correction: Prevention of Hypovolemic Circulatory Collapse by IL-6 Activated Stat3

por Alten, Jeffrey A., Moran, Ana, Tsimelzon, Anna I., Mastrangelo, Mary-Ann A., Hilsenbeck, Susan G., Poli, Valeria, Tweardy, David J.
Publicado 2008

A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis

por Dearth, Robert K, Kuiatse, Isere, Wang, Yu-Fen, Liao, Lan, Hilsenbeck, Susan G, Brown, Powel H, Xu, Jianming, Lee, Adrian V
Publicado 2011

Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression

por Heckman-Stoddard, Brandy M, Vargo-Gogola, Tracy, McHenry, Peter R, Jiang, Vivian, Herrick, Matthew P, Hilsenbeck, Susan G, Settleman, Jeffrey, Rosen, Jeffrey M
Publicado 2009

Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice

por Chiang, Angie C.A., Fowler, Stephanie W., Savjani, Ricky R., Hilsenbeck, Susan G., Wallace, Clare E., Cirrito, John R., Das, Pritam, Jankowsky, Joanna L.
Publicado 2018

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions

por Johnston, A. N., Bu, W., Hein, S., Garcia, S., Camacho, L., Xue, L., Qin, L., Nagi, C., Hilsenbeck, S. G., Kapali, J., Podsypanina, K., Nangia, J., Li, Y.
Publicado 2018

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

por Huang, Catherine, Park, Catherine C, Hilsenbeck, Susan G, Ward, Robin, Rimawi, Mothaffar F, Wang, Yen-chao, Shou, Jiang, Bissell, Mina J, Osborne, C Kent, Schiff, Rachel
Publicado 2011

Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer

por Holdman, Xue B., Welte, Thomas, Rajapakshe, Kimal, Pond, Adam, Coarfa, Cristian, Mo, Qianxing, Huang, Shixia, Hilsenbeck, Susan G., Edwards, Dean P., Zhang, Xiang, Rosen, Jeffrey M.
Publicado 2015

Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer

por Bu, Wen, Chen, Jiang, Morrison, Gladys D., Huang, Shixia, Creighton, Chad J., Huang, Jian, Chamness, Gary C., Hilsenbeck, Susan G., Roop, Dennis R., Leavitt, Andrew D., Li, Yi
Publicado 2011

Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

por Dave, Bhuvanesh, Landis, Melissa D., Dobrolecki, Lacey E., Wu, Meng-Fen, Zhang, Xiaomei, Westbrook, Thomas F., Hilsenbeck, Susan G., Liu, Dan, Lewis, Michael T., Tweardy, David J., Chang, Jenny C.
Publicado 2012

Correction: Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

por Dave, Bhuvanesh, Landis, Melissa D., Dobrolecki, Lacey E., Wu, Meng-Fen, Zhang, Xiaomei, Westbrook, Thomas F., Hilsenbeck, Susan G., Liu, Dan, Lewis, Michael T., Tweardy, David J., Chang, Jenny C.
Publicado 2012

P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis

por McHenry, Peter R, Sears, James C, Herrick, Matthew P, Chang, Peggy, Heckman-Stoddard, Brandy M, Rybarczyk, Megan, Chodosh, Lewis A, Gunther, Edward J, Hilsenbeck, Susan G, Rosen, Jeffrey M, Vargo-Gogola, Tracy
Publicado 2010